Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Canadian Institutes of Health Research and partners fund CCNA's second phase

Thanks to a $46-million investment from the Canadian Institutes of Health Research (CIHR) and other funding partners, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be renewed for a second phase, announced today.

17 Jun 2019

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.

17 Jun 2019

Scientists create 'mini-brain' for studying sporadic Creutzfeldt-Jakob disease

National Institutes of Health scientists have used human skin cells to create what they believe is the first cerebral organoid system, or "mini-brain," for studying sporadic Creutzfeldt-Jakob disease.

16 Jun 2019

Study shows marked impairment of moral emotions in patients with frontotemporal dementia

A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.

16 Jun 2019

Scientists improve working memory by extending brain signals

Researchers have discovered that short term memory can be improved by artificially extending neuronal signals called sharp wave ripples.

14 Jun 2019

'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports.

13 Jun 2019

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Apolipoproten E is a major genetic risk factor for the development of Alzheimer's disease, yet the protein tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease.

13 Jun 2019

Researchers develop first blood-brain barrier chip using stem cells

Researchers at Ben-Gurion University of the Negev and Cedars-Sinai Medical Center in Los Angeles have, for the first time, duplicated a patient's blood-brain barrier, creating a human BBB chip with stem cells, which can be used to develop personalized medicine and new techniques to research brain disorders.

13 Jun 2019

Drink containing multinutrient combination can benefit patients with mild cognitive impairment

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect® can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports

13 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Early life adversity and high levels of FKBP5 protein amplify anxiety-like behavior

Researchers continue to dig for molecular clues to better understand how gene-environment interactions influence neuropsychiatric disease risk and resilience.

11 Jun 2019

Smarter, more educated people get a cognitive 'head start', but aren't protected from Alzheimer's

In a search for clues to what may delay or prevent Alzheimer's disease, Johns Hopkins Medicine scientists report that smarter, more educated people aren't protected from the disease, but do get a cognitive "head start" that may keep their minds functioning better temporarily.

From Johns Hopkins Medicine 11 Jun 2019

New research explores foundational questions about end-of-life choices for people with dementia

As the American population ages and dementia is on the rise, The Hastings Center is embarking on pathbreaking research to explore foundational questions associated with the dementia trajectory and the concerns of persons facing this terminal condition.

8 Jun 2019

CAPON protein may facilitate link between two most well-known Alzheimer's culprits

A new protein involved in Alzheimer's disease has been identified by researchers at the RIKEN Center for Brain Science.

7 Jun 2019

Chemical changes in the brain may be associated with unexplained motor symptoms

A new study finds that people who have movement problems, symptoms that cannot be explained by an underlying disease, may have chemical changes in specific areas of the brain.

6 Jun 2019

Alzheimer's therapy may be effective in treating individuals addicted to opioids

Clinical trial results reveal that a medication used to treat Alzheimer's disease may also be an effective therapy for individuals addicted to opioids. The findings are published in The American Journal on Addictions.

6 Jun 2019

New tool reveals how genes interact to form tissues and organisms

Although the knowledge we have about human cells and tissues has steadily increased over recent decades, many things remain unknown.

4 Jun 2019

Antihypertensive drug use linked with reduction in dementia risk

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence.

3 Jun 2019

Brush your teeth and use floss to slow down Alzheimer's

The researchers have determined that gum disease (gingivitis) plays a decisive role in whether a person develops Alzheimer´s or not.

3 Jun 2019

Laundry packet exposures increase in older children and adults, despite safety standards

A new study conducted by researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children's Hospital and the Central Ohio Poison Center investigated trends in calls to poison control centers across the country for exposure to liquid laundry detergent packets.

3 Jun 2019

Alzheimer's Disease News and Research

Further Reading

Canadian Institutes of Health Research and partners fund CCNA's second phase

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Scientists create 'mini-brain' for studying sporadic Creutzfeldt-Jakob disease

Study shows marked impairment of moral emotions in patients with frontotemporal dementia

Scientists improve working memory by extending brain signals

'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Researchers develop first blood-brain barrier chip using stem cells

Drink containing multinutrient combination can benefit patients with mild cognitive impairment

Scientists identify potential target for Parkinson's treatment

Early life adversity and high levels of FKBP5 protein amplify anxiety-like behavior

Smarter, more educated people get a cognitive 'head start', but aren't protected from Alzheimer's

New research explores foundational questions about end-of-life choices for people with dementia

CAPON protein may facilitate link between two most well-known Alzheimer's culprits

Chemical changes in the brain may be associated with unexplained motor symptoms

Alzheimer's therapy may be effective in treating individuals addicted to opioids

New tool reveals how genes interact to form tissues and organisms

Antihypertensive drug use linked with reduction in dementia risk

Brush your teeth and use floss to slow down Alzheimer's

Laundry packet exposures increase in older children and adults, despite safety standards

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News